Ascendis Pharma A/S Finance Income Received Classified As Operating Activities
Ascendis Pharma A/S (ASND) reported Finance Income Received Classified As Operating Activities of EUR 15.30 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:FinanceIncomeReceivedClassifiedAsOperatingActivities · last filed 2026-02-11
- Ascendis Pharma A/S finance income received classified as operating activities for the quarter ending 2025-12-31 was 4.37M EUR, a 19.78% decline year-over-year.
- Ascendis Pharma A/S finance income received classified as operating activities for the quarter ending 2025-09-30 was 3.33M EUR, a 25.13% increase year-over-year.
- Ascendis Pharma A/S finance income received classified as operating activities for the quarter ending 2025-06-30 was 3.40M EUR, a 26.82% increase year-over-year.
- Ascendis Pharma A/S finance income received classified as operating activities for the quarter ending 2025-03-31 was 4.21M EUR, a 17.28% increase year-over-year.
| Period end | Finance Income Received Classified As Operating Activities 3 month | Finance Income Received Classified As Operating Activities 6 month | Finance Income Received Classified As Operating Activities 9 month | Finance Income Received Classified As Operating Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | 4.37M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 7.70M EUR derived: sum of 2 quarters · filed 2026-02-11 | 11.09M EUR derived: sum of 3 quarters · filed 2026-02-11 | 15.30M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 3.33M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 6.72M EUR derived: sum of 2 quarters · filed 2025-11-12 | 10.93M EUR 6-K · filed 2025-11-12 | 16.38M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 3.40M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 7.60M EUR 6-K · filed 2025-08-07 | 13.05M EUR derived: sum of 3 quarters · filed 2026-02-11 | 15.71M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 4.21M EUR 6-K · filed 2025-05-01 | 9.66M EUR derived: sum of 2 quarters · filed 2026-02-11 | 12.32M EUR derived: sum of 3 quarters · filed 2026-02-11 | 14.99M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | 5.45M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 8.11M EUR derived: sum of 2 quarters · filed 2026-02-11 | 10.79M EUR derived: sum of 3 quarters · filed 2026-02-11 | 14.37M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 2.66M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 5.33M EUR derived: sum of 2 quarters · filed 2025-11-12 | 8.92M EUR 6-K · filed 2025-11-12 | 13.39M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 2.68M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 6.26M EUR 6-K · filed 2025-08-07 | 10.74M EUR derived: sum of 3 quarters · filed 2026-02-11 | 14.91M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 3.59M EUR 6-K · filed 2025-05-01 | 8.06M EUR derived: sum of 2 quarters · filed 2026-02-11 | 12.23M EUR derived: sum of 3 quarters · filed 2026-02-11 | 16.76M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | 4.47M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 8.64M EUR derived: sum of 2 quarters · filed 2026-02-11 | 13.17M EUR derived: sum of 3 quarters · filed 2026-02-11 | 17.05M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 4.17M EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | 8.70M EUR derived: sum of 2 quarters · filed 2024-11-14 | 12.58M EUR 6-K · filed 2024-11-14 | 14.04M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 4.52M EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | 8.40M EUR 6-K · filed 2024-09-03 | 9.87M EUR derived: sum of 3 quarters · filed 2025-02-12 | 12.85M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 3.88M EUR 6-K · filed 2024-05-02 | 5.34M EUR derived: sum of 2 quarters · filed 2025-02-12 | 8.32M EUR derived: sum of 3 quarters · filed 2025-02-12 | 10.30M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 1.46M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 4.44M EUR derived: sum of 2 quarters · filed 2025-02-12 | 6.42M EUR derived: sum of 3 quarters · filed 2025-02-12 | 8.27M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 2.98M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 4.96M EUR derived: sum of 2 quarters · filed 2023-11-07 | 6.81M EUR 6-K · filed 2023-11-07 | 7.59M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 1.98M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | 3.83M EUR 6-K · filed 2023-09-05 | 4.61M EUR derived: sum of 3 quarters · filed 2024-02-07 | 5.61M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 1.85M EUR 6-K · filed 2023-04-27 | 2.63M EUR derived: sum of 2 quarters · filed 2024-02-07 | 3.63M EUR derived: sum of 3 quarters · filed 2024-02-07 | 4.57M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 778.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 1.78M EUR derived: sum of 2 quarters · filed 2024-02-07 | 2.72M EUR derived: sum of 3 quarters · filed 2024-02-07 | 3.70M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 1.00M EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | 1.94M EUR derived: sum of 2 quarters · filed 2022-11-02 | 2.92M EUR 6-K · filed 2022-11-02 | 2.59M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 940.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | 1.92M EUR 6-K · filed 2022-08-10 | 1.59M EUR derived: sum of 3 quarters · filed 2023-02-16 | 1.47M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | 975.00K EUR 6-K · filed 2022-05-11 | 648.00K EUR derived: sum of 2 quarters · filed 2023-02-16 | 525.00K EUR derived: sum of 3 quarters · filed 2023-02-16 | 846.00K EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -327.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | -450.00K EUR derived: sum of 2 quarters · filed 2023-02-16 | -129.00K EUR derived: sum of 3 quarters · filed 2023-02-16 | 1.33M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | -123.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-11-12 | 198.00K EUR derived: sum of 2 quarters · filed 2020-11-12 | 1.65M EUR 6-K · filed 2020-11-12 | 3.62M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | 321.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2020-08-27 | 1.78M EUR 6-K · filed 2020-08-27 | 3.75M EUR derived: sum of 3 quarters · filed 2022-03-02 | 6.92M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | 1.46M EUR 6-K · filed 2020-05-19 | 3.42M EUR derived: sum of 2 quarters · filed 2022-03-02 | 6.59M EUR derived: sum of 3 quarters · filed 2022-03-02 | 9.96M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | 1.97M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 5.14M EUR derived: sum of 2 quarters · filed 2022-03-02 | 8.50M EUR derived: sum of 3 quarters · filed 2022-03-02 | 10.06M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | 3.17M EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-11-12 | 6.53M EUR derived: sum of 2 quarters · filed 2020-11-12 | 8.09M EUR 6-K · filed 2020-11-12 | 9.04M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 3.36M EUR derived: 6-K 6 month − 6-K 3 month · filed 2020-08-27 | 4.92M EUR 6-K · filed 2020-08-27 | 5.87M EUR derived: sum of 3 quarters · filed 2021-03-10 | 6.93M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 1.55M EUR 6-K · filed 2020-05-19 | 2.51M EUR derived: sum of 2 quarters · filed 2021-03-10 | 3.57M EUR derived: sum of 3 quarters · filed 2021-03-10 | 4.87M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 955.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 2.02M EUR derived: sum of 2 quarters · filed 2021-03-10 | 3.32M EUR derived: sum of 3 quarters · filed 2021-03-10 | 4.02M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | 1.06M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | 2.36M EUR derived: sum of 2 quarters · filed 2019-11-18 | 3.06M EUR 6-K · filed 2019-11-18 | 3.54M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | 1.30M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | 2.00M EUR 6-K · filed 2019-08-28 | 2.47M EUR derived: sum of 3 quarters · filed 2020-04-03 | 2.64M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | 702.00K EUR 6-K · filed 2019-05-30 | 1.17M EUR derived: sum of 2 quarters · filed 2020-04-03 | 1.34M EUR derived: sum of 3 quarters · filed 2020-04-03 | 1.50M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | 470.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 635.00K EUR derived: sum of 2 quarters · filed 2020-04-03 | 793.00K EUR derived: sum of 3 quarters · filed 2020-04-03 | 923.00K EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 165.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-11-28 | 323.00K EUR derived: sum of 2 quarters · filed 2018-11-28 | 453.00K EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 158.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-29 | 288.00K EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | 130.00K EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | 123.00K EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | 13.00K EUR 20-F · filed 2018-03-28 |